After Hours Decliner
ANRO Alto Neuroscience23.41+0.93+4.1%
After Hours:22.54-0.87 (-3.7%)
Alto Neuroscience Reports Topline Data from Phase 2 Proof-of-Concept Study of ALTO-101 and Highlights Pipeline Advancements
Business WireWed, 1-Apr 4:30 PM
ANRO Alto Neuroscience14.29+0.49 (+3.6%)
ANRO Alto Neuroscience14.36+2.25 (+18.6%)
ANRO Alto Neuroscience11.20+5.12 (+84.2%)
ANRO Alto Neuroscience6.78+2.37 (+53.7%)
ANRO Alto Neuroscience5.04-9.49 (-65.3%)